SCHEMBL23536720

SCHEMBL23536720

Nc1cc(CC=O)nc(C(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
KDM4E B2RXH2 5/20 0.33
HSD17B10 Q99714 2/20 0.33
GRM4 Q14833 1/20 0.33
KMT2A Q03164 1/20 0.32
CA2 P00918 1/20 0.32
CHKA P35790 1/20 0.32
PTGS2 P35354 1/20 0.31
MAPT P10636 1/20 0.31
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
TSHR P16473 1/20 0.30
CRHBP P24387 1/20 0.30
CYP2C19 P33261 1/20 0.30
CRHR2 Q13324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29250917 0.78 HSP90AA1 (0.41) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL8788157 0.74 HSP90AA1 (0.52) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL30697100 0.73 ALDH1A1 (0.41) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL27076937 0.73 ALDH1A1 (0.41) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL30062263 0.72 ALDH1A1 (0.38) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL27076965 0.72 HSP90AA1 (0.41) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL23611369 0.72 ALDH1A1 (0.38) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10
SCHEMBL20001983 0.71 P2RX7 (0.44)
SCHEMBL29796472 0.71 P2RX7 (0.44)
SCHEMBL31574180 0.70 HSP90AA1 (0.39) ALDH1A1HSP90AA1HSP90AB1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076418-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-10-26 EP disclosed
WO-2021127429-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2021-06-24 WO disclosed